Document Type
Article
Publication Date
8-2020
Identifier
DOI: 10.1038/s41436-020-0815-4; PMCID: PMC7394879
Abstract
PURPOSE: This study characterizes the clinical and genetic features of nine unrelated patients with de novo variants in the NR4A2 gene.
METHODS: Variants were identified and de novo origins were confirmed through trio exome sequencing in all but one patient. Targeted RNA sequencing was performed for one variant to confirm its splicing effect. Independent discoveries were shared through GeneMatcher.
RESULTS: Missense and loss-of-function variants in NR4A2 were identified in patients from eight unrelated families. One patient carried a larger deletion including adjacent genes. The cases presented with developmental delay, hypotonia (six cases), and epilepsy (six cases). De novo status was confirmed for eight patients. One variant was demonstrated to affect splicing and result in expression of abnormal transcripts likely subject to nonsense-mediated decay.
CONCLUSION: Our study underscores the importance of NR4A2 as a disease gene for neurodevelopmental disorders and epilepsy. The identified variants are likely causative of the seizures and additional developmental phenotypes in these patients.
Journal Title
Genetics in medicine : official journal of the American College of Medical Genetics
Volume
22
Issue
8
First Page
1413
Last Page
1417
Keywords
NR4A2; developmental disorder; epilepsy; neurodevelopmental disorder; seizures
Recommended Citation
Singh, S., Gupta, A., Zech, M. et al. De novo variants of NR4A2 are associated with neurodevelopmental disorder and epilepsy. Genet Med 22, 1413–1417 (2020). https://doi.org/10.1038/s41436-020-0815-4
Comments
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Link: https://www.nature.com/articles/s41436-020-0815-4